Ocular Therapeutix
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
OCUL Key Statistics
Stock Snapshot
With a market cap of 3.13B, Ocular Therapeutix(OCUL) trades at $14.75. The stock has a price-to-earnings ratio of -10.21.
On 2025-12-12, Ocular Therapeutix(OCUL) stock moved within a range of $14.50 to $15.57. With shares now at $14.75, the stock is trading +1.7% above its intraday low and -5.3% below the session's peak.
Trading volume for Ocular Therapeutix(OCUL) stock has reached 3.61M, versus its average volume of 4.58M.
Over the past 52 weeks, Ocular Therapeutix(OCUL) stock has traded between a high of $16.44 and a low of $5.79.
Over the past 52 weeks, Ocular Therapeutix(OCUL) stock has traded between a high of $16.44 and a low of $5.79.
OCUL News
In late 2025, Ocular Therapeutix announced it plans to submit a new drug application for its wet age-related macular degeneration therapy AXPAXLI based on year...
Ocular Therapeutix (OCUL) has quietly put up an interesting run lately, with the stock gaining around 44% year to date and roughly 16% over the past month, draw...
Ocular Therapeutix (OCUL) has granted inducement awards to eight newly hired non-executive employees. The awards were made as an inducement material to each rec...